February 3, 2022
Journal of the American Medical Association (JAMA)
American Medical Association
“We characterized natural immunity and long-term durability among unvaccinated individuals using anti–spike antibodies, the first line of defense against SARS-CoV-2…
Discussion: In this cross-sectional study of unvaccinated US adults, antibodies were detected in 99% of individuals who reported a positive COVID-19 test result, in 55% who believed they had COVID-19 but were never tested, and in 11% who believed they had never had COVID-19 infection. Anti-RBD levels were observed after a positive COVID-19 test result up to 20 months, extending previous 6-month durability data.”
© 2023 American Medical Association. All Rights Reserved. This paper was published under Free Access.
document
COVID-19,clinical cases,health statistics,natural immunity,pharmaceuticals